%0
Generic
%T
Results of a randomized, double-blind phase II clinical trial of NY-ESO-1 vaccine with ISCOMATRIX adjuvant versus ISCOMATRIX alone in participants with high-risk resected melanoma
%A Cebon, Jonathan S
%A Gore, Martin
%A Thompson, John F
%A Davis, Ian D
%A McArthur, Grant A
%A Walpole, Euan
%A Smithers, Mark
%A Cerundolo, Vincenzo
%A Dunbar, P Rod
%A MacGregor, Duncan
%A Fisher, Cyril
%A Millward, Michael
%A Nathan, Paul
%A Findlay, Michael P N
%A Hersey, Peter
%A Evans, T R Jeffry
%A Ottensmeier, Christian Hermann
%A Marsden, Jeremy
%A Dalgleish, Angus G
%A Corrie, Pippa G
%A Maria, Marples
%A Brimble, Margaret
%A Williams, Geoff
%A Winkler, Sintia
%A Jackson, Heather M
%A Endo-Munoz, Liliana
%A Tutuka, Candani S A
%A Venhaus, Ralph
%A Old, Lloyd J
%A Haack, Dennis
%A Maraskovsky, Eugene
%A Behren, Andreas
%A Chen, Weisan
%I BMJ
%@ 2051-1426
%D 2020
%C BMJ
%U http://slubdd.de/katalog?TN_libero_mab2